A blog bringing you perspectives from the frontlines of the drug pricing debate.
Claims that pharmacy benefit managers (PBMs) and the rebates they negotiate from drug companies are to blame for…
This week Novo Nordisk – one of the largest drug companies manufacturing GLP-1 weight-loss medications – will testify…
A new Business Group on Health survey of employers uncovered a truth: soaring demand for GLP-1 weight-loss drugs…
In an effort to lower health costs, the U.S. Patent and Trademark Office (USPTO) has proposed new regulations…
For too many Americans, Big Pharma has made prescription drugs expensive or outright unaffordable. But for the last…
Recently, the White House held a listening session to discuss prescription drug prices and the role pharmacy benefit…
As a new year begins, many Americans – including Members of Congress – are rightly asking why drug…
As 2024 begins, it brings an all-too-familiar tradition from big drug companies: a tidal wave of price hikes…
The stakes have rarely been higher for Americans struggling with high drug prices. As the House and Senate…
Labor unions are making headlines across the country this fall – and not just due to high-profile strikes…
